Expert Interview
A Third Look: Discussing the results of the ASCERTAIN-TRD comparative effectiveness research trial for ABILIFY (aripiprazole) in patients with treatment resistant depression
Ticker(s): OTSKYInstitution: Fond du Lac Psychiatry
- boarded in addiction and psychiatry
- currently has about 10 patients who he is pressuring to stop smoking. Has at least another 30 who have turned downs varenicline for fear of side effect. Practice is blue-collar and about 30% are smokers, or about 120 patients
- But I am not familiar with cytisinicline, although I will read up when I’m done sending this. I usually use varenicline, at least in patients who tolerate it. Otherwise I use nicotine patches or Zyn, although I’ve had patients who had a hard time getting off that nicotine.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
